Pharmacology NR566 final Exam review questions and answers. Rated A+ Download to score A+

Pharmacology NR566 final Exam review questions and answers. Rated A+ Download to score A+ Document Content and Description Below Pharmacology NR566 final Exam review questions and answers. Rated A+ For treatment of existing osteoporosis, the dose of alendronate - 10 mg/day or 70 mg/week Initial dosage for bone l ess prevention alendronate and risedronate - 5 mg/day or 35 mg/week For treatment of existing osteoporosis, the dose of risedronate - 75 mg for 2 consecutive days or 150 mg once a month Alendronate (Fosamax) - Therapy with 10 mg daily can increase bone density by up to 10% after 3 years and can decrease vertebral and hip fractures by 50% Testosterone replacement therapy - risk of prostate cancer Testosterone replacement therapy - Erythrocytosis is a risk; Hgb and Hct levels checked, expect increase first 6 mths, unless Hgb level higher than 17.5 g/dL, Hct higher than 54%, or both suggests overtreatment or occasionally abuse. IM happens more than transdermal. If the Hct is greater than 54%, therapy is stopped until the Hct decreases to a safe level. The patient should also be evaluated for hypoxia and sleep apnea. Restarting therapy at a reduced dose usually solves problems. Adults with vitamin B12 deficiency that is not pernicious anemia - 1,000 mcg of oral cobalamin are given until normal B12 levels are achieved—usually 6 to 12 weeks. In seriously ill patients, both vitamin B12 and folic acid may need to be administered. Who cannot get TRT - breast cancer in a male patient, prostrate cancer, polycythemia vera, increased calcium in the blood from cancer, diabetes, high cholesterol, overweight and high blood pressure BC contraindications - Age 40 yr or Smoker 35 yr BMI 30 due to increased VTE risk HTN or hyperlipidemia First-degree relative with DVT/PE Major surgery without prolonged immobilization Superficial thrombophlebitis SLE on immunosuppressive therapy or with severe thrombocytopenia Rheumatoid arthritis Sickle cell disease BC contraindications - Valvular heart disease, uncomplicated Migraine without neurological aura, age 35 yr Unexplained vaginal bleeding, suspicious for serious underlying condition Cervical intraepithelial neoplasia Cervical cancer, awaiting treatment Undiagnosed breast mass BC contraindications - Diabetes, insulin dependent or non-insulin-dependent, without vascular disease Asymptomatic gallbladder disease or postcholecystectomy Benign focal nodular hyperplasia of the liver Hx of cholestasis in pregnancy Ulcerative colitis or Crohn's disease Postpartum & breastfeeding ethinyl estradiol/norgestimate contraindications - Current or prior his